We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.5B
AUM Growth
+$1.05B
Cap. Flow
+$873M
Cap. Flow %
5.29%
Top 10 Hldgs %
11.27%
Holding
3,014
New
224
Increased
984
Reduced
712
Closed
332

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$68.5M
2
NKE icon
Nike
NKE
+$42.4M
3
BA icon
Boeing
BA
+$40.5M
4
NTAP icon
NetApp
NTAP
+$40.2M
5
DIS icon
Walt Disney
DIS
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 14.46%
2 Technology 14.05%
3 Financials 10.89%
4 Consumer Discretionary 10.45%
5 Industrials 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGBN icon
201
Eagle Bancorp
EGBN
$869M
$28.3M 0.17%
588,306
+40,630
+7% +$2M
WEB
202
DELISTED
Web.com Group, Inc.
WEB
$28.1M 0.17%
1,543,891
+314,878
+26% +$5.73M
SKYW icon
203
Skywest
SKYW
$4.11B
$27.9M 0.17%
1,054,256
-469,183
-31% -$10.7M
CINF icon
204
Cincinnati Financial
CINF
$28.1B
$27.9M 0.17%
372,396
+6,895
+2% +$468K
WWW icon
205
Wolverine World Wide
WWW
$1.54B
$27.8M 0.17%
1,370,295
+1,366,141
+32,887% +$25.5M
ARRS
206
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$27.8M 0.17%
1,325,269
+203,033
+18% +$4.61M
CRZO
207
DELISTED
Carrizo Oil & Gas Inc
CRZO
$27.5M 0.17%
767,530
-142,606
-16% -$5.1M
IRDM icon
208
Iridium Communications
IRDM
$4.85B
$27.4M 0.17%
3,087,999
+163,174
+6% +$1.34M
BMY icon
209
Bristol-Myers Squibb
BMY
$127B
$27.2M 0.16%
369,542
-527
-0.1% -$37.2K
CLX icon
210
Clorox
CLX
$11.6B
$27.1M 0.16%
196,075
-88,419
-31% -$11.5M
EMR icon
211
Emerson Electric
EMR
$82.3B
$26.9M 0.16%
514,942
-26,523
-5% -$1.41M
EBS icon
212
Emergent Biosolutions
EBS
$374M
$26.8M 0.16%
954,679
+206,122
+28% +$8.08M
UNH icon
213
UnitedHealth
UNH
$382B
$26.8M 0.16%
189,976
+5,410
+3% +$721K
ZD icon
214
Ziff Davis
ZD
$1.93B
$26.8M 0.16%
488,127
-22,728
-4% -$1.26M
IVV icon
215
iShares Core S&P 500 ETF
IVV
$874B
$26.7M 0.16%
127,000
-2,340
-2% -$488K
AKAM icon
216
Akamai
AKAM
$16.9B
$26.6M 0.16%
475,711
+418,841
+736% +$22M
SWFT
217
DELISTED
Swift Transportation Company
SWFT
$26.5M 0.16%
1,721,613
+403,473
+31% +$6.65M
NTRS icon
218
Northern Trust
NTRS
$22.1B
$26.5M 0.16%
400,318
+31,900
+9% +$2.22M
USMV icon
219
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
$26.4M 0.16%
571,570
+134,920
+31% +$5.99M
HUN icon
220
Huntsman Corp
HUN
$2.26B
$26.4M 0.16%
1,961,179
-153,038
-7% -$2.24M
PVTB
221
DELISTED
PrivateBancorp Inc
PVTB
$26.3M 0.16%
596,550
-25,575
-4% -$1.04M
FNB icon
222
FNB Corp
FNB
$6.78B
$26.2M 0.16%
2,085,545
-263,083
-11% -$3.4M
FLG
223
Flagstar Bank National Association
FLG
$5.76B
$25.8M 0.16%
573,301
+51,197
+10% +$2.33M
TXRH icon
224
Texas Roadhouse
TXRH
$12.6B
$25.7M 0.16%
564,164
-286,282
-34% -$12.7M
MRSH
225
Marsh
MRSH
$86.1B
$25.6M 0.16%
374,499
+33,457
+10% +$2.15M

Similar funds

Glenmede Trust's Q2 2016 Portfolio in Review

As of Q2 2016, Glenmede Trust held 3,014 positions worth $16.5B, up 6.8% from $15.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $873M of net new capital in Q2 2016, opening 224 new positions and adding to 984 existing holdings. Its largest new stake was PARSLEY ENERGY INC: 1,223,959 shares worth $33.1M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cognizant, an estimated $68.5M trimmed.

  • Glenmede Trust's largest Q2 2016 buy was PARSLEY ENERGY INC: 1,223,959 shares worth $33.1M.
  • Glenmede Trust added most to eBay in Q2 2016, an estimated $59.7M increase.
  • Glenmede Trust's biggest Q2 2016 reduction was Cognizant, cutting an estimated $68.5M.
  • Glenmede Trust fully exited Lithia Motors in Q2 2016, selling an estimated $24.4M.
  • Glenmede Trust's ten largest holdings make up 11% of its $16.5B portfolio in Q2 2016.
  • Glenmede Trust opened 224 new positions and closed 332 in Q2 2016.
  • Glenmede Trust's portfolio value rose 6.8% quarter-over-quarter to $16.5B.

Based on Glenmede Trust's 13F filing for Q2 2016, filed 5 Aug 2016.